Is Abattis Bioceuticals Corp. (ATTBF) a Buy, Sell, or Hold?
OTC : ATTBF
Abattis Bioceuticals Corp.
$3e-05 USD
$0 (0.0%)
- Volume
- 2.48K
- Average Volume
- 25.07K
- Market Capitalization
- $14.33K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.73
Company Overview
OTC
Robert G. Goodall
Medical - Pharmaceuticals
Healthcare
ATTBF
48
CA
USD
Liquidity Metrics
0.14
0.73
0.68
0.41
0.00
Sales & Valuation
$356.88K
0.06
0.00
0.00
0.01
Profitability
-$0.0065
-$3.04M
-852.40%
-857.72%
-26.96%
-15.79%
P/E Metrics
-0.01
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-7.97
3/9
-$1.31M
$19.26M
$8.59M
-$3M
Key Metrics (TTM)
-$429.68K
-1.20
0.15
0.73
-26.96%
-25.05%
-15324.05%
21584.31%
310 days
Company Executives
| Name | Title |
|---|---|
| Francesco Paolini | Chief Financial Officer & Director |
| Jim Carter | Head of Mergers and Acquisitions Advisory |
| Patrick Mitchell | Chief Operating Officer & Director |
| Shawn Balaghi | Head of Corporate Development |
| Nicole Breitinger | Corporate Secretary |
| Christopher Cherry | Corporate Comptroller |
Poll Results
No votes yet today — be the first to share your view!
About Abattis Bioceuticals Corp. (OTC:ATTBF) Stock
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. ...
Frequently Asked Questions
-
What is the current Abattis Bioceuticals Corp. (ATTBF) stock price?
-
Abattis Bioceuticals Corp.(OTC:ATTBF) stock price is $3e-05 in the last trading session. During the trading session, ATTBF stock reached the peak price of $0.00003 while $0.000001 was the lowest point it dropped to. The percentage change in ATTBF stock occurred in the recent session was 0.0% while the dollar amount for the price change in ATTBF stock was $0.
-
ATTBF's industry and sector of operation?
-
The OTC listed ATTBF is part of Medical - Pharmaceuticals industry that operates in the broader Healthcare sector.
-
Who are the executives of ATTBF?
-
Francesco Paolini | Chief Financial Officer & Director
Jim Carter | Head of Mergers and Acquisitions Advisory
Patrick Mitchell | Chief Operating Officer & Director
Shawn Balaghi | Head of Corporate Development
Nicole Breitinger | Corporate Secretary -
How many employees does ATTBF have?
-
Number of ATTBF employees currently stands at 48. ATTBF operates from 625 Howe Street, Vancouver, BC V6C 2M6, CA.
-
Link for ATTBF official website?
-
Official Website of ATTBF is: https://www.abattis.com
-
How do I contact ATTBF?
-
ATTBF could be contacted at phone #808 650 3007 and can also be accessed through its website. ATTBF operates from 625 Howe Street, Vancouver, BC V6C 2M6, CA.
-
How many shares of ATTBF are traded daily?
-
The average number of ATTBF shares traded daily for last 3 months was 25.07K.
-
What is the market cap of ATTBF currently?
-
The market value of ATTBF currently stands at $14.33K with its latest stock price at $3e-05